| Biology's new dimension A Abbott Nature 424 (6951), 870, 2003 | 1375 | 2003 |
| Education: the PhD factory D Cyranoski, N Gilbert, H Ledford, A Nayar, M Yahia Nature 472 (7343), 276-279, 2011 | 519* | 2011 |
| CRISPR gene-editing tested in a person for the first time D Cyranoski Nature news 539 (7630), 479, 2016 | 339 | 2016 |
| China's crystal cache: a Chinese laboratory is the only source of a valuable crystal. David Cyranoski investigates why it won't share its supplies D Cyranoski Nature 457 (7232), 953-956, 2009 | 234 | 2009 |
| Do metrics matter? Many researchers believe that quantitative metrics determine who gets hired and who gets promoted at their institutions. With an exclusive poll and … A Abbott, D Cyranoski, N Jones, B Maher, Q Schiermeier, R Van Noorden Nature 465 (7300), 860-863, 2010 | 213 | 2010 |
| Chinese scientists fix genetic disorder in cloned human embryos D Cyranoski Nature News 550 (7674), 15, 2017 | 156 | 2017 |
| Japan stem-cell trial stirs envy: researchers elsewhere can't wait to test iPS cells in humans S Reardon, D Cyranoski Nature 513 (7518), 287-289, 2014 | 140 | 2014 |
| Chinese scientists to pioneer first human CRISPR trial D Cyranoski Nature News 535 (7613), 476, 2016 | 134 | 2016 |
| Stem cells cruise to clinic: Japanese study of induced pluripotent stem cells aims to demonstrate safety in humans D Cyranoski Nature 494 (7438), 413-414, 2013 | 125 | 2013 |
| The coronavirus pandemic in five powerful charts E Callaway, D Cyranoski, S Mallapaty, E Stoye, J Tollefson Nature 579 (7800), 482-483, 2020 | 116 | 2020 |
| Genome-edited baby claim provokes international outcry D Cyranoski, H Ledford Nature 563 (7733), 607-608, 2018 | 107 | 2018 |
| Mystery deepens over animal source of coronavirus. D Cyranoski Nature 579 (7797), 18-19, 2020 | 102 | 2020 |
| 5 things to know before jumping on the iPS bandwagon: induced pluripotent stem cells look just like embryonic stem cells, but are easier to create and free of the heavy ethics … D Cyranoski Nature 452 (7186), 406-409, 2008 | 102 | 2008 |
| SARS: what have we learned? H Pearson, T Clarke, A Abbott, J Knight, D Cyranoski Nature 424 (6945), 121-126, 2003 | 93 | 2003 |
| Cash for papers: putting a premium on publication I Fuyuno, D Cyranoski Nature 441 (7095), 792-792, 2006 | 84 | 2006 |
| Japanese woman is first recipient of next-generation stem cells D Cyranoski Nature News, 2014 | 79 | 2014 |
| Verdict: Hwang's human stem cells were all fakes D Cyranoski Nature 439 (7073), 122, 2006 | 77 | 2006 |
| Korean deaths spark inquiry: cases highlight the challenge of policing multinational trade in stem-cell treatments D Cyranoski Nature 468 (7323), 485-486, 2010 | 72 | 2010 |
| Stem-cell pioneer banks on future therapies: Japanese researcher plans cache of induced stem cells to supply clinical trials D Cyranoski Nature 488 (7410), 139-140, 2012 | 71 | 2012 |
| 'Reprogrammed'stem cells approved to mend human hearts for the first time D Cyranoski Nature 557 (7706), 619-619, 2018 | 69 | 2018 |
